Analystreport

Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at Cantor Fitzgerald to a "hold" rating. They now have a $8.00 price target on the stock.

Pacific Biosciences of California, Inc.  (PACB) 
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.pacificbiosciences.com